Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trialSanjay Ramakrishnan, Mona Bafadhel, Stephen Bright et al.|The Lancet Respiratory Medicine|2021Cited by 434
Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trialSanjay Ramakrishnan, Mona Bafadhel, Helen Jeffers et al.|The Lancet Respiratory Medicine|2023Cited by 70
Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trialSanjay Ramakrishnan, Mona Bafadhel, Dan V. Nicolau et al.|medRxiv|2021Cited by 25
Inhaled Budesonide in the Treatment of Early COVID-19 Illness: A Randomised Controlled TrialSanjay Ramakrishnan, Mona Bafadhel, Dan V. Nicolau et al.|SSRN Electronic Journal|2021Cited by 5
Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trialSanjay Ramakrishnan, Mona Bafadhel, Dan V. Nicolau et al.|Unknown|2021Cited by 5